Literature DB >> 22765255

Estimating preference-based EQ-5D health state utilities or item responses from neuropathic pain scores.

Ning Yan Gu1, Chris Bell, Marc F Botteman, Xiang Ji, John A Carter, Ben van Hout.   

Abstract

BACKGROUND: Preference-based health state utilities are required for many health economic evaluations. When the direct evidence of such is lacking and only condition-specific scores are available, establishing a 'mapping' relationship between instruments can be useful.
OBJECTIVE: Our objective was to map the 11-point Pain Intensity Numerical Rating Scale (PI-NRS-11), a pain-specific instrument ranging from 0 ('no pain') to 10 ('pain as bad as you can imagine'), to the EQ-5D, a preference-based generic instrument.
METHODS: We used web survey data collected from adult US respondents who (i) had ≥ 3 months of neuropathic pain (NP), either painful diabetic peripheral neuropathy (pDPN) or post-herpetic neuralgia (PHN); (ii) were receiving medications treating NP; and (iii) had completed the EQ-5D and PI-NRS-11. We explored indirect and direct mapping approaches. The indirect method took a probabilistic approach using ordered logistic models (OLMs) predicting response levels for each EQ-5D item via repeated Monte Carlo simulations before computing utilities. The direct approach simply predicted EQ-5D utilities directly using ordinary least squares (OLS). Categorical scores of PI-NRS-11 were used as the predictors. Patient age, gender, and pain duration were additionally controlled in the full model specification. Seventy percent of the data were used for estimation and 30% for prediction. Mean square errors (MSEs) and 95% confidence intervals (CIs) of prediction errors were reported.
RESULTS: A total of 2719 respondents were included. Mean (SD) age was 55.48 (10.65) years and 56.23% were female. Average NP duration was 61 months and 58% gave scores ≥ 6 on the PI-NRS-11. The clinical pain scores were significantly associated with all EQ-5D items, especially with the 'pain/discomfort' item (p  <  0.001). The observed mean (SD) EQ-5D index was 0.594 (0.22). Predicted utilities and responses showed good representation of the observed ones. The reduced model showed comparable results with the full model while imposing minimum data collection burden. From the reduced model, the predicted mean (SD) EQ-5D index was 0.594 (0.11) from direct estimation and 0.588 (0.19) from indirect estimation. All estimated utilities discriminated health gains/losses along the PI-NRS-11. Lower MSEs and prediction errors were found for EQ-5D >0.2.
CONCLUSIONS: Findings suggest that EQ-5D utilities or item responses could be estimated on the basis of NP scores. Independent testing of the external validity of the mapping algorithms developed herein is encouraged.

Entities:  

Mesh:

Year:  2012        PMID: 22765255     DOI: 10.1007/bf03262491

Source DB:  PubMed          Journal:  Patient        ISSN: 1178-1653            Impact factor:   3.883


  54 in total

1.  Evaluating quality-adjusted life years: estimation of the health utility index (HUI2) from the SF-36.

Authors:  M B Nichol; N Sengupta; D R Globe
Journal:  Med Decis Making       Date:  2001 Mar-Apr       Impact factor: 2.583

Review 2.  EuroQol: the current state of play.

Authors:  R Brooks
Journal:  Health Policy       Date:  1996-07       Impact factor: 2.980

3.  Assessing proportionality in the proportional odds model for ordinal logistic regression.

Authors:  R Brant
Journal:  Biometrics       Date:  1990-12       Impact factor: 2.571

4.  The subjective experience of acute pain. An assessment of the utility of 10 indices.

Authors:  M P Jensen; P Karoly; E F O'Riordan; F Bland; R S Burns
Journal:  Clin J Pain       Date:  1989-06       Impact factor: 3.442

5.  US valuation of the EQ-5D health states: development and testing of the D1 valuation model.

Authors:  James W Shaw; Jeffrey A Johnson; Stephen Joel Coons
Journal:  Med Care       Date:  2005-03       Impact factor: 2.983

6.  The numeric rating scale for clinical pain measurement: a ratio measure?

Authors:  Craig T Hartrick; Juliann P Kovan; Sharon Shapiro
Journal:  Pain Pract       Date:  2003-12       Impact factor: 3.183

7.  Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale.

Authors:  B S Galer; M P Jensen
Journal:  Neurology       Date:  1997-02       Impact factor: 9.910

8.  Burden of illness in painful diabetic peripheral neuropathy: the patients' perspectives.

Authors:  Mugdha Gore; Nancy A Brandenburg; Deborah L Hoffman; Kei-Sing Tai; Brett Stacey
Journal:  J Pain       Date:  2006-12       Impact factor: 5.820

Review 9.  A primer on health-related quality of life in chronic pain medicine.

Authors:  Thomas R Vetter
Journal:  Anesth Analg       Date:  2007-03       Impact factor: 5.108

Review 10.  The impact of neuropathic pain on health-related quality of life: review and implications.

Authors:  Mark P Jensen; Marci J Chodroff; Robert H Dworkin
Journal:  Neurology       Date:  2007-04-10       Impact factor: 9.910

View more
  7 in total

1.  Mapping painDETECT, a neuropathic pain screening tool, to the EuroQol (EQ-5D-3L).

Authors:  Joseph C Cappelleri; Vijaya Koduru; E Jay Bienen; Alesia Sadosky
Journal:  Qual Life Res       Date:  2016-08-02       Impact factor: 4.147

2.  Impact of Bleeding on Quality of Life in Patients on DAPT: Insights From TRANSLATE-ACS.

Authors:  Amit P Amin; Tracy Y Wang; Lisa McCoy; Richard G Bach; Mark B Effron; Eric D Peterson; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2016-01-05       Impact factor: 24.094

Review 3.  Review of studies mapping from quality of life or clinical measures to EQ-5D: an online database.

Authors:  Helen Dakin
Journal:  Health Qual Life Outcomes       Date:  2013-09-05       Impact factor: 3.186

Review 4.  Cost-effectiveness of adjunct non-pharmacological interventions for osteoarthritis of the knee.

Authors:  Beth Woods; Andrea Manca; Helen Weatherly; Pedro Saramago; Eleftherios Sideris; Christina Giannopoulou; Stephen Rice; Mark Corbett; Andrew Vickers; Matthew Bowes; Hugh MacPherson; Mark Sculpher
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

5.  Cost-utility analysis of transcranial direct current stimulation therapy with and without virtual illusion for neuropathic pain for adults with spinal cord injury in Canada.

Authors:  Min Xi; XiaoWei Shen; Kamilla Guliyeva; Rebecca Hancock-Howard; Peter C Coyte; Brian C F Chan
Journal:  J Spinal Cord Med       Date:  2021       Impact factor: 1.985

6.  Eliciting health state utilities for Dupuytren's contracture using a discrete choice experiment.

Authors:  Ning Yan Gu; Marc F Botteman; Robert A Gerber; Xiang Ji; Roelien Postema; Yin Wan; Grzegorz Sianos; Iain Anthony; Joseph C Cappelleri; Piotr Szczypa; Ben van Hout
Journal:  Acta Orthop       Date:  2013-11-29       Impact factor: 3.717

7.  Impact of herpes zoster and postherpetic neuralgia on the quality of life of Germans aged 50 or above.

Authors:  Desmond Curran; Ruprecht Schmidt-Ott; Ulf Schutter; Jörg Simon; Anastassia Anastassopoulou; Sean Matthews
Journal:  BMC Infect Dis       Date:  2018-10-03       Impact factor: 3.090

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.